IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 34,963,082
- Share change
- +348,169
- Total reported value
- $391,248,464
- Price per share
- $11.19
- Number of holders
- 100
- Value change
- -$45,848,010
- Number of buys
- 54
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
2,729,719
|
$64,532,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.1%
|
2,701,525
|
$63,864,000 | — | 31 Dec 2021 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$62,899,000 | — | 31 Dec 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
2.9%
|
2,553,000
|
$60,353,000 | — | 31 Dec 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.9%
|
2,520,076
|
$59,575,000 | — | 31 Dec 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.6%
|
2,290,282
|
$54,142,000 | — | 31 Dec 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$52,074,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
1,692,707
|
$40,016,000 | — | 31 Dec 2021 | |
| Logos Global Management LP |
13F
|
Company |
1.8%
|
1,550,000
|
$36,642,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
1,514,123
|
$35,794,000 | — | 31 Dec 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.6%
|
1,398,066
|
$33,050,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.5%
|
1,350,400
|
$31,923,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
1.5%
|
1,319,590
|
$31,194,000 | — | 31 Dec 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1%
|
881,085
|
$20,829,000 | — | 31 Dec 2021 | |
| Alphabet Inc. |
13F
|
Company |
0.86%
|
753,187
|
$17,805,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
567,510
|
$13,415,000 | — | 31 Dec 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.57%
|
498,187
|
$11,777,000 | — | 31 Dec 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.52%
|
460,061
|
$10,876,000 | — | 31 Dec 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.49%
|
430,000
|
$10,165,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
312,425
|
$7,386,000 | — | 31 Dec 2021 | |
| AXA S.A. |
13F
|
Company |
0.32%
|
282,102
|
$6,669,000 | — | 31 Dec 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.31%
|
274,322
|
$6,495,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.31%
|
272,161
|
$6,434,000 | — | 31 Dec 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.28%
|
248,631
|
$5,876,000 | — | 31 Dec 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.28%
|
243,343
|
$5,753,000 | — | 31 Dec 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.27%
|
235,695
|
$5,572,000 | — | 31 Dec 2021 | |
| NATIXIS |
13F
|
Company |
0.23%
|
200,000
|
$4,728,000 | — | 31 Dec 2021 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
173,500
|
$4,102,000 | — | 31 Dec 2021 | |
| Michael P. Dillon |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
102,226
mixed-class rows
|
$3,311,116 | — | 04 Oct 2021 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
117,367
|
$2,774,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
114,434
|
$2,705,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
110,563
|
$2,614,000 | — | 31 Dec 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.12%
|
109,000
|
$2,577,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.12%
|
106,705
|
$2,523,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
116,851
|
$2,485,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
104,505
|
$2,471,000 | — | 31 Dec 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.11%
|
92,411
|
$2,185,000 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
92,252
|
$2,181,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
89,330
|
$2,112,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
83,463
|
$1,974,000 | — | 31 Dec 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
75,302
|
$1,780,000 | — | 31 Dec 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.07%
|
63,641
|
$1,505,000 | — | 31 Dec 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
59,200
|
$1,399,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.06%
|
54,974
|
$1,300,000 | — | 31 Dec 2021 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.06%
|
51,882
|
$1,226,000 | — | 31 Dec 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.05%
|
48,200
|
$1,139,000 | — | 31 Dec 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.05%
|
47,517
|
$1,123,000 | — | 31 Dec 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.05%
|
47,000
|
$1,111,000 | — | 31 Dec 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
41,706
|
$986,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
41,503
|
$981,000 | — | 31 Dec 2021 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2022
As of 31 Mar 2022,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,963,082 shares.
The largest 10 holders included
Logos Global Management LP, Avidity Partners Management LP, Canaan Partners X LLC, BlackRock Inc., FEDERATED HERMES, INC., BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Point72 Asset Management, L.P., and BVF INC/IL.
This page lists
100
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
108
Q1 2022 holders
100
Holder diff
-8
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.